Delivery Order SPE2DB22D2206-SPE2DB25FHS58
- Not listed
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, with a ceiling value of $1,720.29 and a period of performance through July 3, 2025. The contract is not set-aside and was awarded on July 2, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp's Corporate Office Division. The contract is for the supply of 4565634429 - CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has a ceiling value of $1,725.24 and is a firm-fixed-price, delivery order contract with an ultimate completion date of August 30, 2024. AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has an ultimate completion date of September 10, 2024 and a ceiling value of $2,690.24. The contract does not have a set-aside designation. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen has been awarded numerous federal contracts to supply a wide range of...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CEFPODOXIME 200 MG TABLET 20S. The order has a ceiling value of $5,088.41 and a completion date of August 29, 2024. AmerisourceBergen, a major pharmaceutical distributor, provides a wide range of essential medical commodities to support federal healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award, valued at $2,156.40, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product, with a period of performance through February 20, 2025. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,150.16, is a delivery order for the supply of 4567178201 CEFPODOXIME 200 MG TABLET 20S. It has an ultimate completion date of February 7, 2025. The contract is a firm fixed-price agreement and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,530.68 firm fixed-price delivery order is for the supply of 4,567,859,134 units of the pharmaceutical product CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of April 10, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This $10,977.48 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The order is for the supply of 4,565,644,561 units of the pharmaceutical product CEFPODOXIME 200 MG TABLET 20S. The contract has an ultimate completion date of September 3, 2024. Amerisourcebergen is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities,...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The $2,156.40 firm fixed-price delivery order was awarded on September 23, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, with an ultimate completion date of September 24, 2024. This contract is not set aside and is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,437.70 firm fixed price delivery order is for the supply of CEFPODOXIME 200 MG TABLET 20S, a prescription medication. The contract has an ultimate completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHS58Delivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of CEFPODOXIME 200 MG TABLET 20S, a pharmaceutical product. The contract has a firm fixed price pricing type, a ceiling value of $5,602.58, and a period of performance ending on July 2, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This delivery order contract is associated with that larger IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.6k | 7/1/25 |